Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of Age
Clinical trial NCT03563222 · TERMINATED
Trial details
- NCT number
- NCT03563222
- Sponsor
- Fresenius Kabi
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-18
- Primary completion
- 2020-11-12
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.